This was the stock's second consecutive day of gains.

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by next year, the latest insurer to address the tedious paperwork process that has been a pain ...

AstraZeneca plans a $50 billion investment to expand its US manufacturing and research capacity by 2030, driven by tariff ...